Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives

NCT04257045 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04257045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives
Lead sponsor
M.D. Anderson Cancer Center
Phase
Observational
Overall status
Completed
Start date
August 21, 2019
Completion date
July 9, 2024
Enrollment
46 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma, deleterious cdh1 gene mutation, deleterious dicer1 gene mutation, deleterious smarca4 gene mutation, deleterious stk11 gene mutation, endometrial carcinoma, fallopian tube carcinoma, ovarian carcinoma, primary peritoneal carcinoma